This study is led by Dr. Amy Hsu from the Bruyère Research Institute and Professor Marc-André Langlois at the University of Ottawa,
and involves many researchers from universities across Canada.
The goals of this study are to build a better understanding about how widespread COVID-19 is in our most vulnerable and
high-risk populations, and to study the level and duration of protection of currently approved COVID-19 vaccines.
About the Project
How our study focuses on our most vulnerable populations.Learn more
Want to know what we are working on? Find out here!Learn more
Help communicate and share our research data.Learn more
Join our study!
Share your perspective and experience in supporting staff who are vaccine hesitant in long-term care homes.Learn more